Event free survival in adults with relapsed ALL who underwent front-line therapy with CALGB 10403.
Year: 2021
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Stanford University, Stanford Health Care, Stanford Medicine
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3168962083
